Dr. Gary Novack was recently quoted in The New York Times and featured by UC Davis Health for his expert perspective on a nationwide recall of prescription eye drops.
As a nationally recognized expert in ophthalmic drug development, clinical research, and regulatory science, Dr. Novack provided insight into the importance of quality standards, manufacturing oversight, and patient safety when it comes to ophthalmic medications. His comments helped explain why contamination concerns involving eye drops are taken seriously and how the regulatory process is designed to identify and address potential issues.
With decades of experience in ophthalmology, pharmaceutical development, and FDA regulatory processes, Dr. Novack is frequently called upon to provide expert commentary on issues affecting eye care professionals and patients alike.
You can read the full coverage here:
- The New York Times: Millions of Eye Drop Bottles Recalled Over Contamination Concerns
- UC Davis Health: 2.5 Million Bottles of Prescription Eye Drops Recalled
Dr. Novack remains committed to advancing ophthalmic science while helping healthcare professionals and the public better understand the research, development, and regulation of ophthalmic therapies.